FDA Office That Guided PDUFA V Gets New Name Highlighting Its Strategic Role
This article was originally published in The Pink Sheet Daily
Executive Summary
Center for Drug Evaluation and Research’s Office of Planning and Informatics has been renamed the Office of Strategic Programs and is playing a major role in implementing FDA’s patient-focused drug development initiative.